Poniard Pharmaceuticals, Inc. (PARD) Posts Q4 Loss of $0.36, Wider than Views
Tweet Send to a Friend
Poniard Pharmaceuticals, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


